Behavioral Economics and Food Choice
Behavioral Economics Concepts Influencing Healthy Food Choice - Pilot 2
1 other identifier
interventional
4
1 country
4
Brief Summary
This is the second in a series of pilot interventions we are conducting to assess how principles from behavioral economics can be applied to improve consumers' food choices. In collaboration with Aramark, the food service vendor, we intend to examine if calorie labeling in different formats impacts consumers choice of bottled beverages in hospital cafeterias. Specifically, we will be testing whether signage that conveys to consumers the number of calories in each bottled beverage will increase the number of zero-calorie beverages sold relative to non-zero-calorie beverages. Likewise, we will test whether signage that conveys calories in exercise equivalents increases the sale of zero-calorie beverages. Lastly, we will test if signage conveying standard calorie information in conjunction with exercise equivalents increases the sale of zero-calorie beverages. We will measure the differential effect of each of these three formats for calorie information.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Feb 2010
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2010
CompletedStudy Start
First participant enrolled
February 1, 2010
CompletedFirst Posted
Study publicly available on registry
February 3, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedNovember 16, 2011
November 1, 2011
3 months
January 29, 2010
November 11, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcome data will comprise of weekly sales and inventory reports provided by each cafeteria. Specifically, we will obtain total sales of the relevant beverages before, during, and after the study.
Weekly sales data collected duing intervention from 2/8/10 through 5/23/10
Study Arms (3)
Calorie information only
EXPERIMENTALPosting calorie information of sugar-sweetened and zero-calorie beverages prominently on a poster.
Exercise Equivalent Information
EXPERIMENTALPosting of only exercise equivalents (e.g. 45 minutes on a treadmill) for both sugar-sweetened and zero-calorie beverages, prominently on a poster.
Calorie and Exercise Equivalent information
EXPERIMENTALPosting of both calorie and exercise equivalent information for both sugar-sweetened and zero-calorie beverages, prominently on a poster.
Interventions
Posting of Calorie information for sugar-sweetened and zero-calorie beverages
Posting of only exercise equivalents (e.g. 45 minutes on a treadmill) for both sugar-sweetened and zero-calorie beverages, prominently on a poster.
Posting of both calorie and exercise equivalents information for both sugar-sweetened and zero-calorie beverages, prominently on a poster.
Eligibility Criteria
You may qualify if:
- Aramark Hospital Cafeteria or Cafe with the ability to provide sales data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- Carnegie Mellon Universitycollaborator
Study Sites (4)
ARAMARK healthcare at North Shore University Health System
Evanston, Illinois, 60201, United States
ARAMARK Healthcare at Henry Ford Hospital
Detroit, Michigan, 48202, United States
ARAMARK healthcare at Main Line Health
Bryn Mawr, Pennsylvania, 19010, United States
ARAMARK healthcare at Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19107, United States
Related Publications (8)
Volpp KG, Pauly MV, Loewenstein G, Bangsberg D. P4P4P: an agenda for research on pay-for-performance for patients. Health Aff (Millwood). 2009 Jan-Feb;28(1):206-14. doi: 10.1377/hlthaff.28.1.206.
PMID: 19124872BACKGROUNDLoewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007 Nov 28;298(20):2415-7. doi: 10.1001/jama.298.20.2415. No abstract available.
PMID: 18042920BACKGROUNDBrownell KD, Frieden TR. Ounces of prevention--the public policy case for taxes on sugared beverages. N Engl J Med. 2009 Apr 30;360(18):1805-8. doi: 10.1056/NEJMp0902392. Epub 2009 Apr 8. No abstract available.
PMID: 19357400BACKGROUNDVolpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, Galvin R, Zhu J, Wan F, DeGuzman J, Corbett E, Weiner J, Audrain-McGovern J. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med. 2009 Feb 12;360(7):699-709. doi: 10.1056/NEJMsa0806819.
PMID: 19213683RESULTVolpp KG, Loewenstein G, Troxel AB, Doshi J, Price M, Laskin M, Kimmel SE. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008 Dec 23;8:272. doi: 10.1186/1472-6963-8-272.
PMID: 19102784RESULTVolpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA. 2008 Dec 10;300(22):2631-7. doi: 10.1001/jama.2008.804.
PMID: 19066383RESULTOgden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006 Apr 5;295(13):1549-55. doi: 10.1001/jama.295.13.1549.
PMID: 16595758RESULTFlegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005 Apr 20;293(15):1861-7. doi: 10.1001/jama.293.15.1861.
PMID: 15840860RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin Volpp, MD, PhD
University of Pennsylvania
- PRINCIPAL INVESTIGATOR
J. Jane S. Jue, MD
Robert Wood Johnson Foundation Clinical Scholars Program at the University of Pennsylvania
- PRINCIPAL INVESTIGATOR
Matthew J Press, MD
Robert Wood Johnson Foundation Clinical Scholars Program at the University of Pennsylvania
- PRINCIPAL INVESTIGATOR
David Asch, MD, MBA
University of Pennsylvania
- PRINCIPAL INVESTIGATOR
George Loewenstein, PhD
Carnegie Mellon University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- RWJF Clinical Scholar
Study Record Dates
First Submitted
January 29, 2010
First Posted
February 3, 2010
Study Start
February 1, 2010
Primary Completion
May 1, 2010
Study Completion
June 1, 2011
Last Updated
November 16, 2011
Record last verified: 2011-11